6533b860fe1ef96bd12c3957

RESEARCH PRODUCT

Sunlight exposure exerts immunomodulatory effects to reduce multiple sclerosis severity

Felix LuessiReinhard HohlfeldRalf A. LinkerKlaus Lehmann-hornHayrettin TumaniCatharina C. GrossClemens WarnkeStefan BittnerAntonios BayasHans Peter HartungMark MühlauLuisa KlotzCarsten LukasAnke SalmenAnke SalmenIsabelle GenneroDennis GörlichF. WeberGabriel Gonzalez-escamillaGisela AntonyFlorence BucciarelliPatrick OstkampTill F. M. AndlauerTill F. M. AndlauerUlf ZiemannTania KümpfelTilman Schneider-hohendorfAndreas Schulte-mecklenbeckRalf GoldBertram Müller-myhsokBertram Müller-myhsokUwe K. ZettlBernhard HemmerKarin LoserHeinz WiendlFrauke ZippSergiu GroppaNadine MykickiBrigitte WildemannFriedemann PaulSven G. MeuthFlorian Then BerghManuel A. FrieseNicholas SchwabMartin StangelBéatrice PignoletDavid BrassatBjörn TackenbergJohanna Breuer

subject

medicine.medical_specialty610 Medicine & healthDiseaseGastroenterologyLesionImmune systemInterferonInternal medicineVitamin D and neurologyMedicineddc:610610 Medicine & healthBeneficial effectsSunlightSystemic lupus erythematosusMultidisciplinaryLow latitudebusiness.industryMultiple sclerosismedicine.diseaseddc:Cardiovascular and Metabolic DiseasesDisease riskmedicine.symptombusinessmedicine.drugCohort study

description

AbstractBackgroundMultiple sclerosis (MS) disease risk is associated with reduced sun exposure. This study assessed the relationship between measures of sun-exposure (vitamin D (vitD), latitude) and MS disease severity, the mechanisms of action, and effect-modification by medication and sun-sensitivity associated MC1R variants.MethodsTwo multi-center cohort studies (nNationMS=946, nBIONAT=991). Outcomes were the multiple sclerosis severity score (MSSS) and the number of Gd-enhancing lesion (GELs). RNAseq of four immune cell populations before and after UV-phototherapy of five MS patients.ResultsHigh serum vitD was associated with reduced MSSS (PNationMS=0.021; PBIONAT=0.007) and reduced risk for disease aggravation (PNationMS=0.032). Low latitude was associated with higher vitD, lower MSSS (PNationMS=0.018), fewer GELs (PNationMS=0.030) and reduced risk for aggravation (PNationMS=0.044). The influence of latitude on disability seemed to be lacking in the subgroup of interferon-β treated patients (interaction-PBIONAT=0.042, interaction-PNationMS=0.053). In genetic analyses, for carriers of MC1R:rs1805008(T), who reported increased sensitivity towards sunlight (PNationMS=0.038), the relationship between latitude und the number of GELs was inversed (PNationMS=0.001). Phototherapy induced a vitD and type I interferon signature that was most apparent in the transcriptome of monocytes (P=1×10−6).ConclusionVitD is associated with reduced MS severity and disease aggravation. This is likely driven by sun-exposure, as latitude also correlated with disability and serum vitD. However, sun-exposure might be detrimental for sun-sensitive patients. A direct induction of type I interferons through sun-exposure could explain a reduced effect of latitude in interferon-β treated patients. This could also explain opposite effects of sun-exposure in MS and the type I interferon and sun-sensitivity-associated disease Lupus.

10.1073/pnas.2018457118https://mediatum.ub.tum.de/doc/1637117/document.pdf